About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Astrazeneca Pharma India Ltd.
BSE Code 506820
ISIN Demat INE203A01020
Book Value 332.64
NSE Code ASTRAZEN
Dividend Yield % 0.39
Market Cap 203862.50
P/E 101.48
EPS 80.36
Face Value 2  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
23-Mar-2026 8240.00 8240.00 8023.50 8154.50 1240 10138933
20-Mar-2026 8436.15 8450.00 8296.30 8304.45 47 392928
19-Mar-2026 8413.00 8452.95 8345.50 8354.45 243 2038862
18-Mar-2026 8484.50 8594.05 8440.00 8495.70 350 2964097
17-Mar-2026 8362.00 8485.65 8313.45 8445.30 177 1488328
16-Mar-2026 8449.65 8449.95 8268.75 8358.20 196 1638351
13-Mar-2026 8521.45 8527.95 8300.00 8389.85 125 1049933
12-Mar-2026 8660.00 8691.25 8564.00 8598.85 283 2446675
11-Mar-2026 8840.00 8850.00 8635.00 8768.50 123 1073840
10-Mar-2026 8771.00 8844.40 8649.85 8801.65 318 2786457
09-Mar-2026 8558.35 8700.00 8476.75 8672.75 420 3607523
06-Mar-2026 8630.35 8749.95 8523.40 8740.10 75 648835
05-Mar-2026 8717.95 8717.95 8510.15 8596.15 369 3177437
04-Mar-2026 8659.40 8717.50 8587.00 8699.60 422 3663108
02-Mar-2026 8399.40 8802.65 8399.40 8798.15 269 2342035
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.